• BIO INX and Readily3D Announce Collaboration to Advance Volumetric Bioprinting with Cutting-edge Gel-MA Based Ink

    Wednesday May 22nd 2024

  • Sequana Medical announces positive outcome of Day 100 meeting with FDA regarding PMA application for alfapump®

    Wednesday May 22nd 2024

  • Galapagos and Blood Centers of America announce strategic collaboration to accelerate Galapagos’ decentralized CAR-T manufacturing network in the U.S.

    Friday May 17th 2024

  • Mithra announces grant of two additional U.S. patents for NEXTSTELLIS®

    Monday May 13th 2024

  • Important Advances in Oxurion's R&D Program on Geographic Atrophy secondary to AMD

    Tuesday May 7th 2024

  • KU Leuven Secures $2.8 Million Grant to Investigate Origins of Crohn’s Disease Fibrosis

    Friday May 3rd 2024

  • Biotalys starts field trials for second biofungicide

    Thursday May 2nd 2024

  • Biotalys Appoints Laura J. Meyer to Board of Directors

    Tuesday April 30th 2024

  • Your news here?

  • V-Bio Ventures leads €20 million Series A financing of Precision oncology company Flindr Therapeutics to advance first-in-class small molecule inhibitors

    Wednesday April 24th 2024

  • Labconsort and NEKTARI join forces for a more sustainable and social industry

    Saturday April 20th 2024

  • BIO INX Complements Advisory Board with Distinguished Industry Leaders

    Thursday April 18th 2024

Strategic Partners